Today in Medicine: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Medicine.

Press releases published on October 15, 2026

Oct. 15, 2026

First Tracks Biotherapeutics Announces $200 Million Private Placement

Indeterminate GlobeNewswire

Oct. 15, 2026

Jyong Biotech Announces Proposed Texas Facility to Support Potential Commercialization of Its Drug Candidates

Indeterminate GlobeNewswire

Oct. 15, 2026

PA Nonprofit Launches New Women’s Health Innovation Program to Close Gaps in Healthcare Innovation

Indeterminate GlobeNewswire

Oct. 15, 2026

Conavi Medical to Showcase FDA-Cleared Hybrid Imaging System at TCT 2026

Indeterminate GlobeNewswire

Oct. 15, 2026

Helus Pharma Appoints Dr. Suresh Durgam to Board of Directors

Indeterminate GlobeNewswire

Oct. 15, 2026

Palvella Therapeutics to Present Phase 3 SELVA and Phase 2 TOIVA Results, Along With New Pediatric Analyses, at 2026 PeDRA Annual Conference

Indeterminate GlobeNewswire

Oct. 15, 2026

SciSparc Announces Transformation into Agentic AI-Powered Technologies, Including Cybersecurity and Finance Technologies

Indeterminate GlobeNewswire

Oct. 15, 2026

Salvia BioElectronics Initiates Pivotal Study with First Patient in the U.S. Receiving Ultra Thin Neuromodulation Implant for Resistant Migraine

Indeterminate GlobeNewswire

Oct. 15, 2026

Eindhovens medtechbedrijf Salvia BioElectronics start grootschalige studie in de VS met flinterdunne implantaten tegen migraine

Indeterminate GlobeNewswire

Oct. 15, 2026

R1 Therapeutics to present Phase 2b trial-in-progress poster for AP306 at ASN Kidney Week 2026

Indeterminate GlobeNewswire

Oct. 15, 2026

Immunocore announces first patient dosed in the Phase 1 trial of IMC-S118AI – its first tissue-specific autoimmune candidate – for patients with type 1 diabetes

Indeterminate GlobeNewswire

Oct. 15, 2026

Why Is Weight Loss Different During Menopause? Common Myths Debunked

Indeterminate GlobeNewswire

Oct. 15, 2026

Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026

Indeterminate GlobeNewswire

Oct. 15, 2026

Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Europe 2026

Indeterminate GlobeNewswire

Oct. 15, 2026

Eclipse Life Sciences Announces Positive Topline Results from Phase 2 BETTIS-1 Study Evaluating EC-104 for Diabetic Macular Edema (DME)

Indeterminate GlobeNewswire

Oct. 15, 2026

Adlai Nortye Enters into Clinical Collaboration with Lilly and Merck KGaA, Darmstadt, Germany to Evaluate Combination of AN4035 and Cetuximab

Indeterminate GlobeNewswire

Oct. 15, 2026

Krystal Biotech Announces Positive Clinical Data for New Dermatology Program KB113 Demonstrating Broad Basal Cell Carcinoma Regression in Patients with Gorlin Syndrome

Indeterminate GlobeNewswire

Oct. 15, 2026

Rethink s’associe à Joe Fresh(MC) et à la Fondation Pharmaprix pour la santé des femmes(MC)

Indeterminate GlobeNewswire

Oct. 15, 2026

Rethink Partners with Joe Fresh™ & Shoppers Foundation for Women's Health™

Indeterminate GlobeNewswire

Oct. 15, 2026

SweetWater Brewing Gives Fans the Chance to Win Tickets to Their Dream Show at AEG Venues Across Georgia

Indeterminate GlobeNewswire